Veng Jean Heng
Papers
1
Total Citations
21
H-Index
1
About
Veng Jean Heng is a radiation oncologist whose research focuses on advancing stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC). Her most-cited work, a 2020 study comparing local control and distant metastasis rates between CyberKnife and conventional SBRT, has garnered 21 citations and provides critical insights into optimizing treatment delivery for lung cancer patients. This research directly addresses a key clinical question—whether advanced robotic radiosurgery platforms offer tangible benefits over standard SBRT techniques in terms of tumor control and systemic disease progression. Beyond this landmark study, Heng’s contributions lie in refining radiotherapy protocols to improve patient outcomes while minimizing toxicity. Her work is particularly valuable for clinicians and researchers seeking evidence-based guidance on technology selection in lung cancer management. By systematically evaluating real-world outcomes, Heng helps bridge the gap between technological innovation and clinical practice. Her research underscores the importance of personalized treatment planning in radiation oncology, making her a notable voice in the ongoing effort to enhance the efficacy and precision of SBRT for NSCLC.
Research Focus
Key Achievements
Top Papers
- 1